These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 19186663)
1. Generic drug price war begins to benefit insurers. Sipkoff M Manag Care; 2009 Jan; 18(1):9-10. PubMed ID: 19186663 [No Abstract] [Full Text] [Related]
2. Why drug prices will go lower. Tully S Fortune; 1993 May; 127(9):56-8, 60, 62 passim. PubMed ID: 10125261 [TBL] [Abstract][Full Text] [Related]
3. Price regulation and generic competition in the pharmaceutical market. Dalen DM; Strøm S; Haabeth T Eur J Health Econ; 2006 Sep; 7(3):208-14. PubMed ID: 16841230 [TBL] [Abstract][Full Text] [Related]
4. The impact of generic substitution on price competition in Finland. Aalto-Setälä V Eur J Health Econ; 2008 May; 9(2):185-91. PubMed ID: 17508226 [TBL] [Abstract][Full Text] [Related]
5. By the numbers. Health plans and coverage of prescription drugs. Thornton D Healthplan; 1998; 39(6):77-8. PubMed ID: 10351351 [No Abstract] [Full Text] [Related]
6. Do generic firms and the Spanish public purchaser respond to consumer price differences of generics under reference pricing? Puig-Junoy J; Moreno-Torres I Health Policy; 2010 Dec; 98(2-3):186-94. PubMed ID: 20630613 [TBL] [Abstract][Full Text] [Related]
7. Why do FEHBP and big unions excel at managing drug costs? Berberabe T Manag Care; 2003 Dec; 12(12):36-9. PubMed ID: 14723101 [No Abstract] [Full Text] [Related]
8. Longer-term implications of the generic prescription drug "price war". London PA J Am Pharm Assoc (2003); 2010; 50(6):758-60. PubMed ID: 21071324 [No Abstract] [Full Text] [Related]
9. Cut pharmaceutical costs, but mind the legal dangers. Abood RR Manag Care; 1997 Aug; 6(8):47-8, 51-4. PubMed ID: 10170246 [No Abstract] [Full Text] [Related]
13. PBMs' rebate income threatened by lawsuits and move to generics. Sipkoff M Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152 [No Abstract] [Full Text] [Related]
14. Branded drug reformulation: the next brand vs. generic antitrust battleground. Amoresano GV Food Drug Law J; 2007; 62(1):249-56. PubMed ID: 17444032 [No Abstract] [Full Text] [Related]
16. A slowdown in health care premium increases is occurring. Fine A Manag Care Q; 2004; 12(2):9-11. PubMed ID: 15685814 [TBL] [Abstract][Full Text] [Related]
17. Focus on the patent cliff to maximize generic savings. Cahn L Manag Care; 2012 Nov; 21(11):28-32. PubMed ID: 23236715 [No Abstract] [Full Text] [Related]
18. Another war on drugs. European countries turn to 'reference pricing' in battle against soaring cost of pharmaceuticals. Hensley S Mod Healthc; 1999 Nov; 29(46):38-9. PubMed ID: 10662043 [No Abstract] [Full Text] [Related]
19. The king of low cost drugs. Kimes M Fortune; 2009 Aug; 160(3):88-90, 92. PubMed ID: 19711707 [No Abstract] [Full Text] [Related]